Epigenetic and risk factors of testicular germ cell tumors: a brief review.

@article{LanderoHuerta2017EpigeneticAR,
  title={Epigenetic and risk factors of testicular germ cell tumors: a brief review.},
  author={Daniel Adrian Landero-Huerta and Rosa Mar{\'i}a Vigueras-Villase{\~n}or and Emiy Yokoyama-Rebollar and Elena Ar{\'e}chaga-Ocampo and Julio C{\'e}sar Rojas-Casta{\~n}eda and Francisco Jim{\'e}nez-Trejo and Margarita Ch{\'a}vez-Salda{\~n}a},
  journal={Frontiers in bioscience},
  year={2017},
  volume={22},
  pages={
          1073-1098
        }
}
Testicular germ cell cancer (TGCT) is the most common malignancy among young adult males, which has become important due to its increased incidence and mortality in the population worldwide. The etiology is multifactorial. Recent studies have shown some associations between the development of isolated TGCT and certain risk factors, such as exposure to endocrine disruptors, cryptorchidism, and family history of cancer, in order to identify the key pieces in carcinogenesis. Some of the most… 
View on PubMed
bioscience.org
14 Citations
Highly Influential Citations
1
Background Citations
2

Figures and Tables from this paper

14 Citations

Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care

The present study provides a comprehensive review of the epigenetic mechanisms–DNA methylation, histone post-translational modifications, bivalent marks, non-coding RNA–associated with TGCT susceptibility, initiation, progression and response to chemotherapy.

PDE11A gene polymorphism in testicular cancer: sperm parameters and hormonal profile

The findings highlight the key role of PDE11A in testis and suggest the presence of an underlying complex and fine molecular mechanism which controls testis-specific gene expression and susceptibility to testicular cancer.

Current insights into interethnic variability in testicular cancers: Population pharmacogenetics, clinical trials, genetic basis of chemotherapy-induced toxicities and molecular signal transduction.

Light is shed on the population pharmacogenetics of testicular cancer, pediatric and adult tumors, current clinical trials, genetic determinants of chemotherapy-induced toxicity in testicularcancer as well as the molecular signal transduction pathways operating in this malignancy.

Cryptorchidism and Testicular Tumor: Comprehensive Analysis of Common Clinical Features and Search of SNVs in the KIT and AR Genes

It is strongly supported that genetic component in CO could be conditioning for the development of TGCT, and KIT gene variants might be determinants in the pathological association between TGCT and CO.

EDCs and male urogenital cancers.

Applying Single-Cell Analysis to Gonadogenesis and DSDs (Disorders/Differences of Sex Development)

The emergence of single-cell genomics and transcriptomics now presents a novel avenue for DSD analysis, for both diagnosis and for understanding the molecular genetic etiology, and has the potential to enhance the understanding of the cellular origins and pathogenesis of DSDs, as well as infertility and gonadal diseases such as cancer.

Early Steps of Mammary Stem Cell Transformation by Exogenous Signals; Effects of Bisphenol Endocrine Disrupting Chemicals and Bone Morphogenetic Proteins

This review summarizes the current knowledge on the actions of BMPs and estrogens in both normal mammary gland development and breast cancer initiation, dissemination, and resistance to treatment, focusing on the dysregulations of these processes by BPA but also by other bisphenols, including BPS and BPF, initially considered as safer alternatives to BPA.

A Potential New Mechanism for Bisphenol Molecules to Initiate Breast Cancer through Alteration of Bone Morphogenetic Protein Signaling in Stem Cells and Their Microenvironment

BPA and its substitute bisphenol S (BPS) have similar impacts on BMP signaling despite their different ER-binding properties, supporting the hypothesis that their biological effects cannot be extrapolated only from their interaction with ER α 66.

Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites

Latinos had higher relative risks in first degree relatives and higher SPM risk compared to non-Latino Whites for most cancers, supporting a need for increased attention to the genetics of early-onset cancer predisposition in Latinos.

Pigment Intensity in Dogs is Associated with a Copy Number Variant Upstream of KITLG

KITLG plays an important role in melanogenesis, and variants upstream of KITLG have been associated with coat color variation in mice as well as hair color in humans consistent with its role in the domestic dog.

References

SHOWING 1-10 OF 123 REFERENCES

Molecular genetics of testicular germ cell tumors.

The study of TGCT genetics could ultimately translate into development of new molecular diagnostic and therapeutic modalities for these tumors and improve the care of patients with these malignancies.

The epigenome of testicular germ cell tumors

Aberrant DNA methylation has the potential to improve current diagnostics by noninvasive testing and might also serve as a prognostic marker for treatment response.

The rise of testicular germ cell tumours: the search for causes, risk factors and novel therapeutic targets

The genetic factors and possible triggers of type II TGCT are examined to highlight target areas for potential new treatments and the transition from gonocytes into spermatogonia is key to those studying TGCTs.

Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.

Evidence supporting the hypothesis of developmental origin of testicular germ cell cancer is summarized, and epidemiological trends suggest a primary role for environmental factors, probably combined with genetic susceptibility.

Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: An overview

A mini‐review will be an overview on the molecular alterations identified in TGCTs and on novel targeted antineoplastic strategies that might help to treat chemotherapy resistantTGCTs.

The Y deletion gr/gr and susceptibility to testicular germ cell tumor.

Data indicate that the Y microdeletion gr/gr is a rare, low-penetrance allele that confers susceptibility to TGCT.

Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells

The hypothesis that CIS/ITGCNU arises from developmentally arrested germ cells, most likely primordial germ cells/gonocytes, at an early time point during intrauterine development is compatible with the hypothesis that the latter have lost the immature germ cell phenotype.

Intratubular Germ Cell Neoplasia in the Pediatric Population: A Case Report

A case report of a 4-month-old male with undifferentiated ITGCN, and a co-morbid mature teratoma, one of only a few cases currently published, contributes to the growing body of evidence of IT GCN in the pediatric population and how little is known about this diagnosis.

Stem cell factor as a novel diagnostic marker for early malignant germ cells

The novel finding that immunohistochemical detection of stem cell factor (SCF), the c‐KIT ligand, is informative in this context is demonstrated in over 400 cases of normal and pathological gonads, as well as TGCT‐derived cell lines, specifically in cases of CIS and GB.

Familial testicular germ cell tumours.

...